These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

688 related items for PubMed ID: 22876617

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Evaluation of oleo-gum resin as directly compressible tablet excipient and release retardant.
    Kumar P, Singh I.
    Acta Pol Pharm; 2010; 67(3):307-13. PubMed ID: 20524434
    [Abstract] [Full Text] [Related]

  • 4. Gastric floating matrix tablets: design and optimization using combination of polymers.
    Prajapati ST, Patel LD, Patel DM.
    Acta Pharm; 2008 Jun; 58(2):221-9. PubMed ID: 18515232
    [Abstract] [Full Text] [Related]

  • 5. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ, Windberg-Baarup A, Neri C, Byway PV, Booth SW, Fitzpatrick S.
    Int J Pharm; 2007 Jun 07; 337(1-2):246-53. PubMed ID: 17306477
    [Abstract] [Full Text] [Related]

  • 6. Iron oxide induced enhancement of mucoadhesive potential of Eudragit RLPO: formulation, evaluation and optimization of mucoadhesive drug delivery system.
    Singh I, Rana V.
    Expert Opin Drug Deliv; 2013 Sep 07; 10(9):1179-91. PubMed ID: 23590289
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of processing variables on the mechanical and release properties of tramadol matrix tablets incorporating Cissus populnea gum as controlled release excipient.
    Adeleye OA, Femi-Oyewo MN, Odeniyi MA.
    Polim Med; 2014 Sep 07; 44(4):209-20. PubMed ID: 25932902
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T, Brouillet F, Kyriacos S, Mroueh M, Amores da Silva P, Bataille B, Chebli C, Cartilier L.
    Eur J Pharm Biopharm; 2007 Mar 07; 65(3):371-8. PubMed ID: 17275270
    [Abstract] [Full Text] [Related]

  • 17. Development of sustained-release matrix tablets of BKP-01-041 (tilorone derivative) containing Hypromellose.
    Chen L, Wang F.
    Pharmazie; 2013 Oct 07; 68(10):796-9. PubMed ID: 24273882
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of khaya gum as a directly compressible matrix system for controlled release.
    Odeku OA, Fell JT.
    J Pharm Pharmacol; 2004 Nov 07; 56(11):1365-70. PubMed ID: 15525442
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.